Please ensure Javascript is enabled for purposes of website accessibility
Micro-Cap Insider
Micro stocks. Maximum profits

June 14, 2023

Buy 2seventy bio (TSVT) on Weakness

This morning, I published my latest recommendation: Buy 2seventy bio (TSVT).

The stock is down 11% because the company announced that it paused a trial of one of its pipeline drugs due to a patient death.

While this is sad news on a personal level, it doesn’t impact my valuation for the stock.


Because my valuation doesn’t include any “credit” for the pipeline, yet I see almost 200% upside.

Therefore, I would use weakness as a buying opportunity (I did).

Rich is a trained economist and Chartered Financial Analyst (CFA). He has researched and invested in stocks for more than 20 years and has become a recognized expert in micro-cap stock investing. He started his career at investment advisory firm Eaton Vance where he covered a wide range of sectors including software and internet, financials, and health care.